Tamara Utermark

775 total citations
14 papers, 626 citations indexed

About

Tamara Utermark is a scholar working on Neurology, Molecular Biology and Oncology. According to data from OpenAlex, Tamara Utermark has authored 14 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 6 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Tamara Utermark's work include Neurofibromatosis and Schwannoma Cases (8 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Axon Guidance and Neuronal Signaling (3 papers). Tamara Utermark is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (8 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Axon Guidance and Neuronal Signaling (3 papers). Tamara Utermark collaborates with scholars based in United States, Germany and United Kingdom. Tamara Utermark's co-authors include Thomas M. Roberts, C. Oliver Hanemann, Hans R. Widlund, Nina Ilić, Jean J. Zhao, Qi Wang, Sang‐Hyun Lee, William J. Muller, J. Dirk Iglehart and Zhigang C. Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Genes & Development and Cancer.

In The Last Decade

Tamara Utermark

14 papers receiving 614 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tamara Utermark United States	12	404	170	160	98	82	14	626
Barbara R. Tschida United States	13	482 1.2×	108 0.6×	93 0.6×	48 0.5×	56 0.7×	19	705
Adrienne L. Watson United States	14	310 0.8×	81 0.5×	247 1.5×	44 0.4×	38 0.5×	22	663
Sybil M. Genther Williams United States	7	430 1.1×	215 1.3×	111 0.7×	57 0.6×	33 0.4×	8	781
David Eaves United States	8	191 0.5×	94 0.6×	307 1.9×	69 0.7×	33 0.4×	9	539
P. Cornaglia‐Ferraris Italy	18	370 0.9×	94 0.6×	292 1.8×	47 0.5×	76 0.9×	67	734
Hideo Takeshima Japan	13	219 0.5×	166 1.0×	62 0.4×	45 0.5×	113 1.4×	18	512
John J. Halliday United States	7	309 0.8×	231 1.4×	69 0.4×	97 1.0×	303 3.7×	9	731
Ludger Klewes Canada	15	437 1.1×	80 0.5×	139 0.9×	85 0.9×	104 1.3×	18	634
Maria Cristina Picchio Italy	12	500 1.2×	252 1.5×	111 0.7×	52 0.5×	43 0.5×	15	1.0k
Manfred Schwab Germany	8	336 0.8×	218 1.3×	152 0.9×	49 0.5×	103 1.3×	8	573

Countries citing papers authored by Tamara Utermark

Since Specialization

Citations

This map shows the geographic impact of Tamara Utermark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamara Utermark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamara Utermark more than expected).

Fields of papers citing papers by Tamara Utermark

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamara Utermark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamara Utermark. The network helps show where Tamara Utermark may publish in the future.

Co-authorship network of co-authors of Tamara Utermark

This figure shows the co-authorship network connecting the top 25 collaborators of Tamara Utermark. A scholar is included among the top collaborators of Tamara Utermark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamara Utermark. Tamara Utermark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Utermark, Tamara, Fabienne Schmit, Sang‐Hyun Lee, et al.. (2014). The Phosphatidylinositol 3-Kinase (PI3K) Isoform Dependence of Tumor Formation Is Determined by the Genetic Mode of PI3K Pathway Activation Rather than by Tissue Type. Journal of Virology. 88(18). 10673–10679. 9 indexed citations

Schmit, Fabienne, Tamara Utermark, Sen Zhang, et al.. (2014). PI3K isoform dependence of PTEN-deficient tumors can be altered by the genetic context. Proceedings of the National Academy of Sciences. 111(17). 6395–6400. 57 indexed citations

Utermark, Tamara, Hailing Cheng, Qi Wang, et al.. (2012). The p110α and p110β isoforms of PI3K play divergent roles in mammary gland development and tumorigenesis. Genes & Development. 26(14). 1573–1586. 112 indexed citations

Ilić, Nina, Tamara Utermark, Hans R. Widlund, & Thomas M. Roberts. (2011). PI3K-targeted therapy can be evaded by gene amplification along the MYC-eukaryotic translation initiation factor 4E (eIF4E) axis. Proceedings of the National Academy of Sciences. 108(37). E699–708. 175 indexed citations

Lee, Sang‐Hyun, Shidong Jia, Yanni Zhu, et al.. (2011). Transgenic Expression of Polyomavirus Middle T Antigen in the Mouse Prostate Gives Rise to Carcinoma. Journal of Virology. 85(11). 5581–5592. 6 indexed citations

Utermark, Tamara, et al.. (2008). Impaired intercellular adhesion and immature adherens junctions in merlin‐deficient human primary schwannoma cells. Glia. 56(5). 506–515. 28 indexed citations

Utermark, Tamara, Brian Schaffhausen, Thomas M. Roberts, & Jean J. Zhao. (2007). The p110α Isoform of Phosphatidylinositol 3-Kinase Is Essential for Polyomavirus Middle T Antigen-Mediated Transformation. Journal of Virology. 81(13). 7069–7076. 24 indexed citations

Hanemann, C. Oliver, et al.. (2006). Differential gene expression between human schwannoma and control Schwann cells. Neuropathology and Applied Neurobiology. 32(6). 605–614. 32 indexed citations

Utermark, Tamara, et al.. (2006). Reduced Apoptosis Rates in Human Schwannomas. Brain Pathology. 15(1). 17–22. 22 indexed citations

10.

Grönholm, Mikaela, Taru Muranen, Garabet G. Toby, et al.. (2006). A functional association between merlin and HEI10, a cell cycle regulator. Oncogene. 25(32). 4389–4398. 26 indexed citations

11.

Utermark, Tamara, et al.. (2005). Rearrangements of the intermediate filament GFAP in primary human schwannoma cells. Neurobiology of Disease. 19(1-2). 1–9. 15 indexed citations

12.

Hirokawa, Yumiko, Anjali Tikoo, John Huynh, et al.. (2004). A Clue to the Therapy of Neurofibromatosis Type 2. The Cancer Journal. 10(1). 20–25. 76 indexed citations

13.

Utermark, Tamara, Alexi K. Alekov, Holger Lerche, et al.. (2003). Quinidine impairs proliferation of neurofibromatosis type 2‐deficient human malignant mesothelioma cells. Cancer. 97(8). 1955–1962. 15 indexed citations

14.

Utermark, Tamara, et al.. (2003). Pathological Adhesion of Primary Human Schwannoma Cells is Dependent on Altered Expression of Integrins. Brain Pathology. 13(3). 352–363. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact